Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)
China
· Delayed Price · Currency is CNY 3.110
-0.190 (-5.76%)
Oct 11, 2024, 3:04 PM CST
Hubei Biocause Pharmaceutical Market Cap
Hubei Biocause Pharmaceutical has a market cap or net worth of 15.37 billion as of October 11, 2024. Its market cap has decreased by -4.60% in one year.
Market Cap
15.37B
Enterprise Value
33.77B
Revenue
43.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.11
Market Cap Chart
Since March 21, 2005, Hubei Biocause Pharmaceutical's market cap has increased from 1.62B to 15.37B, an increase of 846.26%. That is a compound annual growth rate of 12.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition